insulin analogs (Scios/Pfizer)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameinsulin analogs (Scios/Pfizer)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInsulin receptor agonistsOrnithine decarboxylase stimulants
TargetsInsulin receptorOrnithine decarboxylase
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesScios Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesScios IncPfizer Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A